Users online: 1425    [ij] [ij] [ij] 
Email id

Research Journal of Pharmacy and Technology
Year : 2019, Volume : 12, Issue : 7
First page : ( 3547) Last page : ( 3550)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.5958/0974-360X.2019.00604.8

Comparison Visfatin level between Obese and Non Obese, Hypertensive and Normotensive patients with Ischemic Heart Disease

Al-Kraity Wijdan Rajh Hamza1, Jawad Murtadha M.2

1Department of the Pathological Analysis Techniques, College of Al-Toosi University, Najaf, Iraq

2Technical Institute of AL-Diwaniyah, AL-Furat AL-Awsat Technical University, Najaf, Iraq

Corresponding Author E-mail: wijdanrh.sc12p@uokufa.edu.iq, murtadham.alkhafaji@student.uokufa.edu.iq

Online published on 24 December, 2019.


In the current study, seventy of patients who suffering of IHD and the control group was composed of 20 healthy. The samples were collected from the Coronary Care Unit (CCU) in Al-Sadder Teaching Hospital in Al-Najaf province/Iraq, during the period from September till December 2018. The ages of patients and control ranged from 30 to 69 years old. The Patients groups are divided into subgroup according blood pressure and Body mass index. The results of current study revealed significant differences between IHD group and healthy group, significantly increased (p<0.05) in serum visfatin level and W.C., BMI compared with healthy group. The results indicated a significant increased (p<0.05) in serum VF level of hypertensive group compared with normotensive group in IHD patients. The results indicated when compared with different BMI (normal, over, obese and morbid weight) groups of IHD, there was a significant increase (p>0.05) in VF concentration among different BMI. The result indicated positive correlation between BMI, W.C.) and (VF).


The current study concluded that visfatin level were good marker for detection and diagnosis of ischemic heart disease, and visfatin highly related with risk factors of ischemic heart disease such as hypertensive blood pressure and obesity.



Ischemic heart disease, Visfatin, Obesity and Hypertension.


║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
574,692,347 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.